Korean Regulatory Post Marketing Surveillance for Somavert
NCT05131100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-07-04
Summary
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Conditions
Interventions
- DRUG
-
Somavert
As provided in real world practice
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-13
- Primary Completion
- 2026-09-15
- Completion
- 2026-09-15
Countries
- South Korea
Study Locations
More Related Trials
-
Samsca Post Marketing Surveillance Study
NCT02722863 ·Status: COMPLETED
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
NCT01146938 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
NCT02176850 ·Status: COMPLETED
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
NCT01615198 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg
NCT01918358 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
NCT00796159 ·Status: COMPLETED
-
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
NCT01256411 ·Status: COMPLETED ·Phase: PHASE2
-
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
NCT00923611 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
NCT04686643 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
NCT00549510 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
NCT06121518 ·Status: COMPLETED ·Phase: PHASE3
-
Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
NCT03219632 ·Status: COMPLETED
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
NCT01785472 ·Status: COMPLETED ·Phase: PHASE3
-
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
NCT06273254 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers
NCT02916901 ·Status: COMPLETED ·Phase: PHASE1
-
Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension
NCT02203916 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
NCT00937534 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
NCT05931224 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
NCT05526703 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
NCT06857955 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AD-209
NCT05631990 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
NCT05878561 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT01228682 ·Status: UNKNOWN
-
Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients
NCT02515331 ·Status: COMPLETED ·Phase: PHASE2